A metabolite of riluzole
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

N-hydroxy Riluzole

Item No. 33999

Technical Information
Formal Name
N-hydroxy-6-(trifluoromethoxy)-2-benzothiazolamine
CAS Number
179070-90-7
Molecular Formula
C8H5F3N2O2S
Formula Weight
Purity
≥95%
A solid
Acetonitrile: solubleDMSO: soluble
SMILES
FC(F)(OC1=CC=C2NC(SC2=C1)=NO)F
InChi Code
InChI=1S/C8H5F3N2O2S/c9-8(10,11)15-4-1-2-5-6(3-4)16-7(12-5)13-14/h1-3,14H,(H,12,13)
InChi Key
MFGRTKLVQQZZIE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    N-hydroxy Riluzole is a metabolite of the antiglutamatergic agent riluzole (Item No. 14577).1 It is formed from riluzole predominantly by the cytochrome P450 (CYP) isoform CYP1A2 in human hepatic microsomes.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sanderink, G.J., Bournique, B., Stevens, J., et alInvolvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J. Pharmacol. Exp. Ther. 282(3), 1465-1472 (1997).